Lushang Freda Pharmaceutical Co.,Ltd.'s low P/S ratio is lik...
Lushang Freda Pharmaceutical Co.,Ltd.'s low P/S ratio is likely due to anticipated poor revenue performance. The company's declining revenue and negative growth forecast compared to the industry's positive outlook justify its low P/S ratio.
The Market Doesn't Like What It Sees From Lushang Freda Pharmaceutical Co.,Ltd.'s (SHSE:600223) Revenues Yet As Shares Tumble 28%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment